Literature DB >> 29545424

Chronic myelogenous leukaemia with a p53 mutation demonstrated neutrophilic granulocytes with nuclear hypolobation (pseudo-Pelger-Hüet anomaly) and hypogranulation in the peripheral blood smear.

Motoharu Shibusawa1, Jiro Tadokoro1, Masaru Kojima2, Makoto Kashimura1.   

Abstract

A 70-year-old man visited our emergency department, whose laboratory test results revealed leucocytosis, anaemia, thrombocytopenia and high levels of serum lactate dehydrogenase. In addition, the peripheral blood smear revealed neutrophilic granulocytes with nuclear hypolobation (pseudo-Pelger-Hüet anomaly), hypogranulation and no myeloperoxidase reactivity. Genetic testing of the peripheral blood sample was as follows: G-band, 46XY,t(9;22)(q34;q11.2) (20/20); fluorescence in situ hybridisation BCR/ABL fusion signal, 97%; and analysis of exons 5-9 of the p53 gene, mutation (Pro72Arg) in exon 4 protein. On the basis of these findings, the patient was diagnosed with chronic myelogenous leukaemia (CML) in chronic phase with a p53 mutation and treated with hydroxyurea, dasatinib and nilotinib. Neutrophilic granulocytes with the anomalies were no longer observed after achieving cytogenetic remission. To the best of our knowledge, this is the first report of CML case with the anomalies, in which a p53 mutation without chromosome 17 abnormalities was identified. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Haematology (drugs and medicines); malignant and benign Haematology

Mesh:

Year:  2018        PMID: 29545424      PMCID: PMC5878374          DOI: 10.1136/bcr-2017-221907

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Correlation between acquired pseudo-Pelger-Huet anomaly and involvement of chromosome 17 in chronic myeloid leukemia.

Authors:  M Sessarego; F Ajmar
Journal:  Cancer Genet Cytogenet       Date:  1987-04

2.  17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.

Authors:  V Soenen; C Preudhomme; C Roumier; A Daudignon; J L Laï; P Fenaux
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

3.  Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.

Authors:  J L Laï; M Zandecki; P Fenaux; F Le Baron; F Bauters; A Cosson; M Deminatti
Journal:  Cancer Genet Cytogenet       Date:  1990-06

4.  Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.

Authors:  K Kuriyama; M Tomonaga; T Matsuo; I Ginnai; M Ichimaru
Journal:  Br J Haematol       Date:  1986-08       Impact factor: 6.998

5.  Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemia.

Authors:  Yin Xu; Michelle M Dolan; Phuong L Nguyen
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.